SCOTTSDALE, Arizona, February 22, 2021 (ISSUEWIRE) – Praxsyn Corporation (OTC: PXYN, the “Company”) and Frank Brady, its former Chief Executive Officer have settled the outstanding litigation with the U.S. Securities and Exchange Commission (SEC). See the SEC’s litigation release on this matter: https://www.sec.gov/litigation/litreleases/litrelarchive/litarchive2020.htm (Litigation Release No. 24807 (April 28, 2020)). As a consequence of the settlement of this SEC complaint, Frank Brady resigned from the Board of Directors and as CEO. In connection with Mr. Brady’s resignation, Daniel Oswald was appointed Interim CEO of the Company. All other remaining members of the Board of Directors have since resigned. Since his appointment, Mr. Oswald has been assessing the current state of the Company, and we plan to provide further updates for our shareholders over the next several months. The official announcement can be found here: https://www.praxsyn.com
About Praxsyn Corporation
Headquartered in Scottsdale, Arizona, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward Looking Statement This Press Release contains forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering new business, anticipated sources of funds, including proceeds from future operations and plans, objectives, expectations and intentions contained in the Press Release that are not historical facts such as “estimated gross”…prospective resources, total potential revenue, substantially exceeds, etc. “Because these forward looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release.
Contact: Daniel Oswald, CEO
7904 E CHAPARRAL RD STE A110-210
SCOTTSDALE AZ 85250